Study of Immediate Start of Progestin Contraceptives in Medical Abortion
Quickstart
Immediate Initiation of Progestin Contraceptives in First Trimester Medical Abortion: A Randomized Controlled Trial
1 other identifier
interventional
937
2 countries
8
Brief Summary
This study will compare immediate to post-abortion start of two progestin-based contraceptives (DMPA and etonorgestrel implants) among women having first trimester medical abortion who wish to use that method for post-abortion contraception.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Jul 2013
Typical duration for phase_4
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 15, 2013
CompletedFirst Posted
Study publicly available on registry
July 18, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedMarch 4, 2016
March 1, 2016
2.4 years
July 15, 2013
March 3, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Medical Abortion Failure
One month after enrollment
Repeat Pregnancy
6 months after enrollment
Study Arms (2)
Quickstart
ACTIVE COMPARATORImmediate start
Afterstart
ACTIVE COMPARATORDelayed start
Interventions
Eligibility Criteria
You may qualify if:
- Women having medical abortion desiring progestin-based contraceptives (injectables or implants)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Planned Parenthood of the Pacific Southwest
Chula Vista, California, United States
Planned Parenthood Northern California
Eureka, California, United States
Planned Parenthood of Southern New England
Stamford, Connecticut, United States
Bayview Medical Center
Baltimore, Maryland, United States
Boston Medical Center
Boston, Massachusetts, United States
Planned Parenthood League of Massachusetts
Boston, Massachusetts, United States
Centro de Salud Beatriz Velasco de Aleman
Mexico City, Mexico
Centro de Salud Santa Catarina
Mexico City, Mexico
Related Publications (2)
Raymond EG, Weaver MA, Louie KS, Tan YL, Bousieguez M, Arangure-Peraza AG, Lugo-Hernandez EM, Sanhueza P, Goldberg AB, Culwell KR, Kaplan C, Memmel L, Sonalkar S, Jamshidi R, Winikoff B. Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial. Obstet Gynecol. 2016 Oct;128(4):739-45. doi: 10.1097/AOG.0000000000001627.
PMID: 27607859DERIVEDRaymond EG, Weaver MA, Tan YL, Louie KS, Bousieguez M, Lugo-Hernandez EM, Arangure-Peraza AG, Sanhueza P, Kaplan C, Sonalkar S, Goldberg AB, Culwell KR, Memmel L, Jamshidi R, Winikoff B. Effect of Immediate Compared With Delayed Insertion of Etonogestrel Implants on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial. Obstet Gynecol. 2016 Feb;127(2):306-12. doi: 10.1097/AOG.0000000000001274.
PMID: 26942358DERIVED
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2013
First Posted
July 18, 2013
Study Start
July 1, 2013
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
March 4, 2016
Record last verified: 2016-03